| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |